Literature DB >> 15736187

Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.

Philip J Lee1, Robert Langer, V Prasad Shastri.   

Abstract

The role of n-methyl pyrrolidone (NMP) as an enhancer for permeants delivered from an aqueous phase was investigated in the transdermal delivery of the local anesthetics lidocaine free base, lidocaine-hydrochloride (HCl), and prilocaine-HCl. Lidocaine free-base flux increased from H2O/NMP binary systems containing over 50% (v/v) NMP with significant flux enhancement observed above 80% NMP. In this range, drug flux was found to correlate with NMP flux. The addition of oleic acid (1% w/v) further enhanced lidocaine flux sixfold, in these formulations. The H2O/NMP (50% v/v) system enhanced the transport of water-soluble hydrochloride salt derivatives of lidocaine and prilocaine by factors of 4.3 and 2.6, respectively, indicating that NMP was capable of enhancing hydrophilic and hydrophobic drugs from an aqueous phase. These findings were consistent with the model that NMP flux across the stratum corneum improves the transport of formulation solutes. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736187     DOI: 10.1002/jps.20291

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Large Size Microneedle Patch to Deliver Lidocaine through Skin.

Authors:  Himanshu Kathuria; Hairui Li; Jing Pan; Seng Han Lim; Jaspreet Singh Kochhar; Chunyong Wu; Lifeng Kang
Journal:  Pharm Res       Date:  2016-07-11       Impact factor: 4.200

2.  Investigation of the transdermal transport of charged local anesthetics in the presence of triterpene saponin glycosides.

Authors:  Christopher J Pino; Michael A Scherer; V Prasad Shastri
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

3.  Synthesis and Gelation Characteristics of Photo-Crosslinkable Star Poly(ethylene oxide-co-lactide-glycolide acrylate) Macromonomers.

Authors:  Seyedsina Moeinzadeh; Saied Nouri Khorasani; Junyu Ma; Xuezhong He; Esmaiel Jabbari
Journal:  Polymer (Guildf)       Date:  2011-08-18       Impact factor: 4.430

Review 4.  Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems.

Authors:  Ahlam Zaid Alkilani; Jehad Nasereddin; Rania Hamed; Sukaina Nimrawi; Ghaid Hussein; Hadeel Abo-Zour; Ryan F Donnelly
Journal:  Pharmaceutics       Date:  2022-05-28       Impact factor: 6.525

5.  Solubility improvement of drugs using N-methyl pyrrolidone.

Authors:  Ritesh Sanghvi; Ryuichi Narazaki; Stephen G Machatha; Samuel H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2008-02-20       Impact factor: 3.246

6.  In vitro-in vivo correlation in skin permeation.

Authors:  D Mohammed; P J Matts; J Hadgraft; M E Lane
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

7.  The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis.

Authors:  Marta Roche-Molina; Bryn Hardwick; Cristina Sanchez-Ramos; David Sanz-Rosa; Dirk Gewert; Francisco M Cruz; Andres Gonzalez-Guerra; Vicente Andres; Joaquin A Palma; Borja Ibanez; Grahame Mckenzie; Juan A Bernal
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

8.  Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride.

Authors:  D Prasanthi; P K Lakshmi
Journal:  ISRN Pharm       Date:  2012-12-20

9.  Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion.

Authors:  Faiyaz Shakeel; Sanjula Baboota; Alka Ahuja; Javed Ali; Sheikh Shafiq
Journal:  J Nanobiotechnology       Date:  2008-07-09       Impact factor: 10.435

10.  Enhancement strategies for transdermal drug delivery systems: current trends and applications.

Authors:  Delly Ramadon; Maeliosa T C McCrudden; Aaron J Courtenay; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2021-01-20       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.